Company intelligence / Profile preview
Unitehprom BSU
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
Overview
Unitehprom BSU is an accredited scientific organization with over two decades of experience developing, manufacturing, and commercializing original pharmaceuticals—especially anticancer agents—and pharmaceutical substances. It operates under GMP standards with a full innovation cycle from R&D to mass production. Key products include “Cisplacel” and “Temodex” for local chemotherapy of malignant brain tumors. The company also produces generic pharmaceutical substances such as temozolomide[1][2].
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Unitehprom BSU.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Unitehprom BSU.